| B-cell Lymphoma |
27.9% |
| Mantle Cell Lymphoma |
16.4% |
| Multiple Myeloma |
13.9% |
| Non-hodgkin's Lymphoma |
11.8% |
| Chronic Lymphocytic Leukaemia |
9.0% |
| Lymphoma |
3.3% |
| Diffuse Large B-cell Lymphoma |
2.7% |
| Prophylaxis |
1.9% |
| B-cell Small Lymphocytic Lymphoma |
1.7% |
| Mantle Cell Lymphoma Recurrent |
1.6% |
| Non-hodgkin's Lymphoma Recurrent |
1.3% |
| Waldenstrom's Macroglobulinaemia |
1.3% |
| Follicle Centre Lymphoma, Follicular Grade I, Ii, Iii |
1.2% |
| Diffuse Large B-cell Lymphoma Recurrent |
1.0% |
| Extranodal Marginal Zone B-cell Lymphoma (Malt Type) |
1.0% |
| Nodal Marginal Zone B-cell Lymphoma |
1.0% |
| Splenic Marginal Zone Lymphoma |
0.9% |
| Acute Myeloid Leukaemia |
0.8% |
| Infection Prophylaxis |
0.8% |
| Chemotherapy |
0.6% |
